AAV delivery of RNA editing machinery rescues SUDEP and seizure phenotype in a mouse model of Dravet Syndrome
Chilcott, E. M.; Antinao Diaz, J. F.; Barbanoj, A. A.; Moore, M.; Keegan, A.; Waddington, Z.; Fang, V.; Schorge, S.; Lignani, G.; Waddington, S. N.; Karda, R.
Show abstract
Dravet syndrome (DS) is a severe childhood genetic epilepsy, caused by de novo heterozygous mutations in SCN1A, resulting in a loss-of-function of the voltage-gated sodium ion channel, Nav1.1. Nav1.1 is expressed in the brain, and at a lower level, in the heart. DS manifests in the first year of life. Patients exhibit tonic-clonic seizures, febrile seizures, cognitive decline, developmental delays, ataxia, and sudden unexpected death from epilepsy (SUDEP). We have developed a novel AAV-F mediated CRISPR-Cas-inspired RNA targeting system (CIRTS) preclinical treatment to increase endogenous Scn1a and ameliorate the disease phenotype in a clinically-relevant heterozygous loss-of-function mouse model of DS. We designed novel guide RNAs (gRNAs) to target the long non-coding RNA, (or natural antisense transcript) of Scn1a to increase the expression of Scn1a mRNA in DS mice. We show that intracerebroventricular and intravenous administration of AAV-F-CIRTS-gRNA9 to target the brain and the heart to neonatal Scn1a+/-mice resulted in a significant increase in survival, and a reduction in SUDEP, febrile seizures and seizure duration. These findings provide proof-of-concept evidence that an AAV-F-CIRTS mediated therapy hold promise as a potential treatment for DS.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Administration of barcoded AAV capsid library to the putamen of non-human primates identifies variants with efficient retrograde transport 93%
- Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations 93%
- AAV-mediated gene therapy for Sialidosis 93%
Similar papers in this journal
- A preclinical pig model of Angelman syndrome mirrors the early developmental trajectory of the human condition 92%
- Developmental HCN channelopathy results in decreased neural progenitor proliferation and microcephaly in mice 92%
- Dopaminergic Neurodegeneration Induced by Parkinson's Disease-Linked G2019S LRRK2 is Dependent on Kinase and GTPase Activity 91%
Similar papers in this journal
- Neurodevelopmental defects in Dravet syndrome Scn1a+/- mice: targeting GABA-switch rescues behavioral dysfunctions but not seizures and mortality. 92%
- Comparisons of dual isogenic human iPSC pairs identify functional alterations directly caused by an epilepsy associated SCN1A mutation 92%
- Novel Mouse Model of Alternating Hemiplegia of Childhood Exhibits Prominent Motor and Seizure Phenotypes 92%
Similar papers in this journal
- RNAi-mediated rheostat for dynamic control of AAV-delivered transgenes 93%
- CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro 93%
- A toolbox of astrocyte-specific, serotype-independent adeno-associated viral vectors using microRNA targeting sequences. 93%
Similar papers in this journal
- Parallel functional testing identifies enhancers active in early postnatal mouse brain 94%
- Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome 93%
- SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.